The Peptide Gray Zone: What the FDA's New Ruling Really Means for Your Practice
The FDA's Pharmacy Compounding Advisory Committee just voted to recommend adding six peptides to the 503 bulk list, but what does that actually mean for physicians, med spas, and patients? In this episode of Skytale Insights, host Ben Hernandez sits down with Michael Byrd and Brad Adatto, co-founders of ByrdAdatto, a business and healthcare law firm representing physicians, licensed providers, sponsors, and strategics across the med spa and precision healthcare space. Connect with Michael Byrd and Brad Adatto: ByrdAdatto Website: https://byrdadatto.com/ Email Website: info@byrdadatto.com Connect with Skytale Group: Website Facebook Instagram LinkedIn






